Women's Sport Summit Europe and Women's Health Week Europe are taking place at the Emirates Stadium in London - Women’s Sport Summit on 6 October, Women's Health Week Europe on 7 and 8 October. Both are built around one thing: putting the right people in the same room, to make new deals, partnerships and connections.
Women's Sport Summit Europe brings together 400+ rights holders, brands, investors, athletes, governing bodies and broadcasters, with curated matchmaking and expert panels, keynotes and the innovator pitch competition alongside it.
Women's Health Week Europe is a two day-event with 700+ senior decision-makers and 80+ speakers, including investors, founders, multinationals, providers, services and policymakers, all coming together to turn conversations into partnerships and investment into commercial progress.
The pitch competitions put the most promising early-stage founders in front of that audience, live, with the investors, partners and buyers who can help them scale.
Below are the finalists pitching at each event, and the judges who will pick the winners:
Women's Sport Summit Europe
The finalists
S3 Edge is an evidence-based movement training platform built to reduce ACL injuries in female football players, who tear their ACL at two to eight times the rate of their male counterparts. Founded by Cheryl Geiser, who has spent over 20 years coaching female football athletes at club and collegiate level, and Elizabeth Gazda, whose background is in sports performance and athlete development, S3 Edge gives coaches the tools to correct the movement patterns that put female athletes at risk. Built on three pillars, Stability, Symmetry and Control, its movement system and team-based accountability supplement traditional training to keep athletes in the game.
The Seismic Solution is a woman-founded venture developing a science-informed bra that dynamically adapts to the body during movement. By addressing both the short- and long-term implications of bra wear, the company aims to improve breast support while preserving natural biomechanics, with potential applications across women's health, sports performance and clinical care. Its team of leading experts is developing a wearable design that works with breast deformation rather than against it, creating support that responds to the body instead of restricting it.
Vitelle is the intelligence layer for female performance. It establishes individualised physiological baselines that help teams understand how each athlete responds and adapts over time, turning complex data into actionable intelligence for performance, recovery and athlete care.
Unravel Health offers lab-grade hormone tracking from the bathroom shelf. Its at-home saliva monitoring platform tracks women's changing physiology daily, capturing hormonal patterns that one-off blood tests miss. Founded by three women, including a doctor trained in hospital medicine and clinical research, Unravel Health is on a mission to close the data gap in women's hormone health.
LUNER
LUNER is an intelligent coaching, development and injury prevention platform for female team sports. It combines everyday squad management with an AI risk engine that analyses player data to adapt evidence-based training for the athletes who need it most. By delivering automated injury protection, streamlined operations and biological education for players, coaches and guardians, LUNER equips grassroots clubs with the tools to support female athletes at scale.
The judges
- Katharine Curran, Monarch Collective
- Samir Beg Ceric, Ceric & Co
- Hugo Sever, APEX
- Alex Teasdale, RFU
Women's Health Week Europe
Consumer & tech: the finalists
yume is the lifelong AI companion and winglady for women's hormonal health. Rather than focusing on a single condition or life stage, yume wires together what the health system can't, helping women build body literacy, connect the dots across their health story and take confident, preventative action as their needs change and evolve.
Flow Neuroscience is a medically regulated digital health company offering a clinically validated, wearable headset to treat depression from home. Combining a CE-marked medical device using transcranial direct current stimulation (tDCS) with a structured behavioural therapy app, Flow has already supported over 66,000 users worldwide, with 77% seeing an improvement in their symptoms within three weeks, which can include better sleep, mood and focus. Backed by robust clinical evidence and regulatory clearance across the UK, EU, US and Australia, Flow is on a mission to make effective mental health treatment more accessible, affordable and stigma-free.
July Health delivers end-to-end specialised care for chronic, overlapping conditions including PMOS, PMDD and endometriosis, while advancing deep-context longitudinal real-world datasets.
nuvō8 is building a new model of women's healthcare and workplace menopause support. Founded by Dr Jennifer Cooney, a health physiologist (PhD) and lifestyle medicine practitioner with a background in academia and NHS research, its scalable, systems-based approach brings multidisciplinary expertise into the workplace, connecting manager training and health education with ongoing support and a pathway to one-to-one care for those who need it most. Its mission: meaningful improvements in women's health that translate into real outcomes for business.
yōjō is a wellness company that trains the nervous system. A wearable worn in the ear stimulates the vagus nerve for thirty minutes a day, an app personalises every session, and human coaches keep members consistent. Drug-free and backed by a decade of science, yōjō helps people recover from stress, sleep deeper and feel unshakeable again.
Fertilia was founded from first-hand experience of how much this journey costs, financially, emotionally and physically, while the system meets people one appointment at a time. It brings results and questions together in one place, translates medical terminology into plain English, and helps people arrive at their next appointment already knowing what to ask, so they're not doing it alone. It is built around one rule that matters more than any feature: what it does, and doesn't do.
Align Life is on a mission to help the world heal faster by making holistic wellbeing a first choice, not an afterthought. It is the UK's most comprehensive holistic wellness marketplace, spanning established therapies to emerging and culturally rooted practices, including acupuncture, energy healing, breathwork and somatic therapies. Seekers are matched by AI to services that fit their goals, with hundreds of bookable options including 1:1 sessions, group classes, events and retreats, while practitioners get a platform that showcases their credentials and connects them with aligned clients.
Consumer & tech: the judges
- Sarah Finegan, Antler
- Henriette Hessen, Verdane
- Sapna Shah, Sie Ventures
- Dominnique Karetsos, Amboy Street Ventures
Medical & therapeutics: the finalists
Diamics empowers patients with discreet, at-home STI testing, delivering gold-standard laboratory precision through a simple, credit-card-sized rapid test.
80 Beats Medical is building the next generation of cardiovascular diagnostics for women. Using a simple, non-invasive cuff measurement, its technology captures multiple cardiovascular and hemodynamic biomarkers beyond conventional blood pressure. Starting in pregnancy, the company is developing risk assessment for hypertensive disorders such as preeclampsia, with a vision of bringing deeper cardiovascular insight into routine care across the female life course.
ATB Antivirals, based in Turku, Finland, develops novel proprietary antiviral therapies that target the virus itself rather than only the symptoms it causes, building on decades of academic research in antiviral drug discovery. Its lead programme is a topical anti-HPV therapy designed to target HPV-infected cells, starting with genital warts and with cervical and genital precancerous lesions as a potential future expansion. ATB is also developing a triple-action nasal spray for the prevention of respiratory viral infections, and is advancing its programmes toward first-in-human clinical development and future global partnering.
Gesthera is a women's health biopharmaceutical company dedicated to developing innovative therapies for maternal health. Its lead programme, GST001, is a first-in-class, orally available product candidate in clinical development to treat spontaneous preterm labour and prolong pregnancy at earlier gestational ages, where every additional day in utero matters.
Fecundis is a reproductive biotech company working to improve IVF outcomes and reduce the physical, emotional and financial burden of repeated fertility treatment. Its proprietary sperm capacitation technology has been translated into HyperSperm™, its lead product for IVF, which improves sperm preparation before fertilisation and has demonstrated an increase in usable embryos per treatment, giving more patients a better chance of success from each cycle.
Monix Health is a Swiss deep-tech company building a wearable microneedle biosensor for continuous, real-time monitoring of female hormones. Starting with IVF, Monix is building the continuous data layer for women's hormonal health.
Apikal Tx is 18 months from IND with ST420, a first-in-class, disease-modifying PIK3CA inhibitor for endometriosis, which affects around 10% of adult women and currently has no options beyond NSAIDs, hormone therapy or surgery. PIK3CA hyperactivation is present in all endometriosis lesions, and the company has shown it is a causative factor. Unlike existing PIK3CA inhibitors, ST420 is active on both mutant and wild-type forms without causing hyperglycaemia or hyperinsulinaemia, enabling use outside oncology, with potential across a pipeline of women's health conditions including uterine fibroids and lupus nephritis.
Medical & therapeutics: the judges
- Jen Roberts-Woods, Borski Fund
- Tatum Getty, THENA Capital
- Laurence Blazianu, Panakes
- Triin Linamagi, Sie Ventures
- Annie Theriault, Cross Border Impact Ventures
Final tickets available for Women’s Sport Summit and Women’s Health Week
- Women's Sport Summit Europe: 6 October, Emirates Stadium, London - register here
- Women's Health Week Europe: 7-8 October, Emirates Stadium, London - register here
- Register for both events: please contact Callum Sipson at callum@wplatform.co
